NPS Pharmaceuticals (NPSP) Mildly Higher after FDA Backing
Get Alerts NPSP Hot Sheet
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) resumes after FDA panel backing for Gattex. Shares are currently up about 1% to $10.29.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kenon Holdings (KEN) halted, news pending
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Avalonbay Communities (AVB) dropped from S&P 500
Create E-mail Alert Related Categories
FDA, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share